1 / 8

Respiratory Drug Delivery Market worth 52.37 Billion USD by 2021

Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) - Forecasts to 2021

ritikatyagi97
Télécharger la présentation

Respiratory Drug Delivery Market worth 52.37 Billion USD by 2021

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MarketsandMarkets Presents Pulmonary/ Respiratory Drug Delivery Market Insights on Scope and Growing Demands 2021 https://www.marketsandmarkets.com/Market-Reports/pulmonary-respiratory-drug- delivery-market-179682410.html

  2. ➢ [150 Pages Report] The global respiratory drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by increasing preference of pulmonary technological developments in the form of smart/digital inhalers and rising incidences of respiratory diseases such as COPD, asthma, and cystic fibrosis. ➢ The respiratory drug delivery market by formulation segment is further divided into device type and formulation type. The market, by device type, is categorized into metered dose inhalers, dry powder inhalers, and nebulizers. The dry powder inhalers segment is expected to witness the highest growth during the forecast period due to the advantages associated with the use of these inhalers, such as short administration & preparation time, ease of use, and fewer irritant effects. ➢ The respiratory drug delivery market, based on formulation type, is segmented into suspension aerosol, solution aerosol, and dry powder formulation. The dry powder formulation segment is expected to witness the highest growth during the forecast period due to improved dosage accuracy, minimized dosage variability, and improved flow of drug particles. route of drug delivery, increasing https://www.marketsandmarkets.com/Market-Reports/pulmonary-respiratory-drug- delivery-market-179682410.html

  3. Early buyers will receive 10% customization on Reports. https://www.marketsandmarkets.com/Market-Reports/pulmonary-respiratory-drug- delivery-market-179682410.html

  4. ➢ Based on applications, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other applications (cardiovascular disease, diabetes, respiratory therapy, and treatment of patients on ventilators). The asthma segment accounts for the major share in the market during the forecast period due to increasing prevalence of asthma across the globe. ➢ Currently, North America dominates the pulmonary drug delivery devices market, and Asia represents the second-largest regional market. Moreover, the Asian market is expected to register the highest CAGR during the forecast period due to the rapidly growing geriatric population, growing adoption of an unhealthy lifestyle, growing urbanization, exposure to smoke & chemicals, and the subsequent increase in the prevalence of COPD in the region. https://www.marketsandmarkets.com/Market-Reports/pulmonary-respiratory-drug- delivery-market-179682410.html

  5. ➢ Presently, North America dominates the respiratory drug delivery market, and Europe represents the second-largest regional market. increasing technological developments in the form of digital inhalers developed by various companies and supportive reimbursement policies in the form of Medicare and Medicaid. This is attributed to ➢ Prominent players in the respiratory drug delivery market include GlaxoSmithKline (U.K.), Boehringer Ingelheim GmbH (Germany), 3M (U.S.), AstraZeneca plc (U.K.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Omron Corporation (Japan), and Sunovion Pharmaceuticals Inc. (U.S.). ➢ To speak to our analyst for a discussion on the above findings, click Speak to Analyst https://www.marketsandmarkets.com/Market-Reports/pulmonary-respiratory-drug- delivery-market-179682410.html

  6. About MarketsandMarkets MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. https://www.marketsandmarkets.com/Market-Reports/pulmonary-respiratory-drug- delivery-market-179682410.html

  7. Contact Us Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 Email: sales@marketsandmarkets.com Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/ Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets https://www.marketsandmarkets.com/Market-Reports/pulmonary-respiratory-drug- delivery-market-179682410.html

More Related